378 related articles for article (PubMed ID: 9482905)
1. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1.
Bléry M; Kubagawa H; Chen CC; Vély F; Cooper MD; Vivier E
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2446-51. PubMed ID: 9482905
[TBL] [Abstract][Full Text] [Related]
2. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
[TBL] [Abstract][Full Text] [Related]
3. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
4. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
Nakamura K; Brauweiler A; Cambier JC
J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
[TBL] [Abstract][Full Text] [Related]
5. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
6. Fcgamma receptor-mediated inhibition of human B cell activation: the role of SHP-2 phosphatase.
Koncz G; Pecht I; Gergely J; Sármay G
Eur J Immunol; 1999 Jun; 29(6):1980-9. PubMed ID: 10382761
[TBL] [Abstract][Full Text] [Related]
7. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.
Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP
J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386
[TBL] [Abstract][Full Text] [Related]
8. Co-clustering of Fcgamma and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein.
Koncz G; Tóth GK; Bökönyi G; Kéri G; Pecht I; Medgyesi D; Gergely J; Sármay G
Eur J Biochem; 2001 Jul; 268(14):3898-906. PubMed ID: 11453982
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis reveals multiple distinct sites within Fc gamma receptor IIB that function in inhibitory signaling.
Fong DC; Brauweiler A; Minskoff SA; Bruhns P; Tamir I; Mellman I; Daeron M; Cambier JC
J Immunol; 2000 Oct; 165(8):4453-62. PubMed ID: 11035084
[TBL] [Abstract][Full Text] [Related]
10. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
Yusa S; Catina TL; Campbell KS
J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by fcgamma RIIB.
Bruhns P; Vely F; Malbec O; Fridman WH; Vivier E; Daeron M
J Biol Chem; 2000 Dec; 275(48):37357-64. PubMed ID: 11016922
[TBL] [Abstract][Full Text] [Related]
12. SHP-1/immunoreceptor tyrosine-based inhibition motif-independent inhibitory signalling through murine natural killer cell receptor Ly-49A in a transfected B-cell line.
Motoda K; Takata M; Kiura K; Nakamura I; Harada M
Immunology; 2000 Jul; 100(3):370-7. PubMed ID: 10929060
[TBL] [Abstract][Full Text] [Related]
13. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
Henshall TL; Jones KL; Wilkinson R; Jackson DE
J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
[TBL] [Abstract][Full Text] [Related]
14. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors.
Burshtyn DN; Lam AS; Weston M; Gupta N; Warmerdam PA; Long EO
J Immunol; 1999 Jan; 162(2):897-902. PubMed ID: 9916713
[TBL] [Abstract][Full Text] [Related]
15. FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells.
Fournier N; Chalus L; Durand I; Garcia E; Pin JJ; Churakova T; Patel S; Zlot C; Gorman D; Zurawski S; Abrams J; Bates EE; Garrone P
J Immunol; 2000 Aug; 165(3):1197-209. PubMed ID: 10903717
[TBL] [Abstract][Full Text] [Related]
16. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
Yusa S; Campbell KS
J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
[TBL] [Abstract][Full Text] [Related]
17. Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation.
Malbec O; Fong DC; Turner M; Tybulewicz VL; Cambier JC; Fridman WH; Daëron M
J Immunol; 1998 Feb; 160(4):1647-58. PubMed ID: 9469421
[TBL] [Abstract][Full Text] [Related]
18. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1.
Maeda A; Scharenberg AM; Tsukada S; Bolen JB; Kinet JP; Kurosaki T
Oncogene; 1999 Apr; 18(14):2291-7. PubMed ID: 10327049
[TBL] [Abstract][Full Text] [Related]
19. Chicken Ig-like receptor B2, a member of a multigene family, is mainly expressed on B lymphocytes, recruits both Src homology 2 domain containing protein tyrosine phosphatase (SHP)-1 and SHP-2, and inhibits proliferation.
Viertlboeck BC; Crooijmans RP; Groenen MA; Göbel TW
J Immunol; 2004 Dec; 173(12):7385-93. PubMed ID: 15585863
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases.
Le Dréan E; Vély F; Olcese L; Cambiaggi A; Guia S; Krystal G; Gervois N; Moretta A; Jotereau F; Vivier E
Eur J Immunol; 1998 Jan; 28(1):264-76. PubMed ID: 9485206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
